Company profile
Establishment Labs Holdings Inc.
NASDAQ: ESTA · Healthcare · Medical - Devices
PublicHQ Austin, CIK 0001688757Reports USD
#288 of 1,418 Healthcare companies by revenue70th-percentile growth
EA Score
59CFH 53DQ 61GM 67SS 72
v0.1 · 65/100 weight · provisional
↑ market scale, workforce scale · ↓ return on equity, balance-sheet leverage
Methodology →Revenue TTM
$229.6M
Rev growth YoY (TTM)
+34.9%
Net income (FY)
-$51.1M
Employees
1,004
as of 2026-07-19
Market cap
$2.6B
as of 2026-07-19
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$211.1M$211.1M2025
Net income-$51.1M-$51.1M2025
Operating income-$39.0M-$39.0M2025
Total assets$357.2M$357.2M2025
Liabilities$333.6M$333.6M2025
Equity$23.5M$23.5M2025
Revenue trend
FY2019 – FY2025 · USD
FY19
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Establishment Labs Holdings Inc.’s revenue?
Establishment Labs Holdings Inc. booked $211.1M in FY2025 revenue, growing 27% year over year — faster than most Healthcare companies we track, at a -24.2% net margin.
Peers · Healthcare
IDEAYA Biosciences, Inc.67BVanda Pharmaceuticals Inc.63CTreace Medical Concepts, Inc.55CCanopy Growth Corporation59CCytek Biosciences, Inc.58CSI-BONE, Inc.70BKey facts
CEOFillipo Peter Caldini
SectorHealthcare
IndustryMedical - Devices
HeadquartersAustin, null
ExchangeNASDAQ: ESTA
Employees1,004
IPO date2018-07-19
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.